BREAKTHROUGH THERAPIES
For Orphan and High Need Diseases Including Cancer
BLR Bio is a privately held biotechnology company on the leading edge of fibro-inflammatory therapy development and a leader in developing therapeutics targeting the myofibroblast - a novel approach to address a broad spectrum of Fibrotic Diseases and Cancer
Our fibrosis therapies restore equilibrium to the areas of the body where inflammation and fibrosis persist.
Our cancer therapies restore antitumor immunity and suppress cancer cell proliferation and spread.
Copyright © 2025 BLRBio - All Rights Reserved.
Powered by GoDaddy